Skip to main content
. 2021 May-Aug;15(2):78–85. doi: 10.5005/jp-journals-10078-1305

Table 2.

Comparison of demographic data and clinical characteristics between POAG, NTG, and PACG patients

Demographic characteristic POAG (N = 60) NTG (N = 52) PACG (N = 52) p value
Mean age (at first diagnosis) (mean, SD) 63.0 (9.4) 59.6 (10.3) 62.3 (8.5) 0.148@
Mean age (at recruitment) (mean, SD) 68.2 (9.4) 65.6 (8.8) 66.2 (8.7) 0.269@
Duration of follow-up (mean, SD) 5.4 (4.4) 6.2 (4.4) 4.2 (3.3) 0.037 @
Sex (n, %)
  Male 43 (71.7) 30 (57.7) 19 (36.5) 0.001 #
  Female 17 (28.3) 22 (42.3) 33 (63.5)
Ethnicity (n, %)
  Malay 30 (50.0) 32 (61.6) 33 (63.5) 0.597*
  Chinese 28 (46.7) 18 (34.6) 17 (32.7)
  Indian 2 (3.3) 2 (3.8) 2 (3.8)
Type of glaucoma (n, %) 60 (36.6) 52 (31.7) 52 (31.7)
Central cornea thickness, μm (mean, SD) 527.6 (28.1) 515.6 (31.0) 512.8 (40.7) 0.118@
Systemic disease
  Hypertension (n, %) 44 (73.3) 38 (73.1) 29 (55.8) 0.085 #
  Diabetes mellitus (n, %) 27 (45.0) 10 (19.2) 15 (28.8) 0.012 #
  Ischemic heart disease (n, %) 14 (23.3) 8 (15.4) 6 (11.5) 0.236#
  Hyperlipedemia (n, %) 22 (36.7) 23 (44.2) 18 (34.6) 0.566#
BMI (mean, SD) 23.1 (3.5) 24.8 (5.5) 25.8 (4.0) 0.004 @
Waist circumference (mean, SD) 89.6 (11.1) 94.6 (11.2) 95.6 (10.2) 0.008 @
Neck circumference (mean, SD) 37.4 (8.3) 35.9 (4.1) 36.4 (6.0) 0.454@
APAC (n, %)
  No 35 (67.3)
  Yes 17 (32.7)
AGIS score (n, %)
  Early 12 (20.0) 7 (13.9) 8 (15.4) 0.828*
  Mild 23 (38.3) 24 (46.1) 18 (34.6)
  Moderate 16 (26.7) 15 (28.7) 15 (28.8)
  Severe 7 (11.7) 5 (9.5) 7 (13.5)
End-stage 2 (3.3) 1 (1.8) 4 (7.7)

BMI, body mass index; APAC, acute presentation of angle-closure; AGIS, advanced glaucoma intervention study

#

p < 0.05 is considered statistical significance based on Pearson's Chi-square

*

p < 0.05 is considered statistical significance based on Fisher's exact test

@

p < 0.05 is considered statistical significance based on one-way ANOVA